David R. Lynch, MD, PhD

Neurology
Independent provider
Accepting new patients
Sees patients age 18 and up
Penn Neuroscience Center - Neurology

About me

  • Professor of Neurology
  • Professor of Neurology in Pediatrics

My education and training

  • Medical School: Johns Hopkins University School of Medicine
  • Residency: University of Pennsylvania Health System
  • Fellowship: University of Pennsylvania Health System

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Lynch is an independent physician who is not employed by Penn Medicine.

Qualifications and experience

Treatments and Conditions

Research

Publications

Morgan C Devore 1, Christina Lam 2, Emily Xiao 2, Jeremy Devore 2, Kassandra R C McCain 2, Graham Wiley 3, Courtney C Park 4, David R Lynch 4, Sanjay I Bidichandani FXN protomutations are the source of pathogenic expanded GAA alleles in Friedreich ataxia and explain its unequal population distribution , Hum Mol Genet , 35(11): 2026 ,ddag046.


Ali SAH, Early J, Farmer JM, Gelbard S, Corben L, Rance G, Lynch DR. Listening in Spatialized Noise-Sentences (LiSN-S) as a Measure of Auditory Function in Friedreich Ataxia. , Cerebellum, 25(3): 2026,60


Gaetz W, Saleh MG, Birnbaum C, Bloy L, Roberts TPL, Lynch DR. Myo-inositol elevation as an in vivo marker of reactive gliosis in pediatric Friedreich ataxia: evidence from HERMES-edited MR spectroscopy , Neuroimage: Clinical, 50:: 2026,103983.


Lazaropolous, MP, Devore, M, Bidichandani, SJ, LynchD.R. Compound Heterozygote Friedreich Ataxia Patients With Covert Proximal FXN Gene Deletion , Annals of Clinical and Translational Neurology: 2026


Gitman, a., Bhandari, N., Castellano, M, Schadt, K., Cancio, M, Lynch, D. R. Stem cell transplantation in Friedreich ataxia: Cure for Leukemia but no effect on neurological progression , Annals Clinical and Translational Neurol: 2026


Satoshi Miyashita, Anthony Zaki, Kaitlin Schlabach, Gabriel Kim, Juliane K. Vierecke, David Lynch, Carmela Tan, Eileen Hsich, Paulino Alvarez Advanced Heart Failure in Friedreich's Ataxia: A Story of Challenges, Opportunities, and Hope , JACC: Case Reports: 2026


Morgan C. Devore, Christina Lam, Emily Xiao, Jeremy Devore, Kassandra R.C. McCain, Graham Wiley, Courtney C. Park, David R. Lynch, Sanjay I. Bidichandani FXN protomutations are the source of pathogenic expanded GAA alleles in Friedreich ataxia and explain its unequal population distribution , Human Mol Genet: 2026


Rummey C, Thomas-Black G, Garcia-Moreno H, Lynch DR, Abeti R, Arisoy H, Heslegrave A, Zetterberg H, Giunti P; European Friedreich's Ataxia Consortium for Translational Studies (EFACTS). Increase of Plasma Biomarkers in Friedreich's Ataxia: Potential Insights into Disease Pathology , Movement disorders, 409: 2025,1863-1873.


David R. Lynch, Angie Goldsberry, Christian Rummey, Jennifer Farmer, Sylvia Boesch, Martin B. Delatycki, Paola Giunti, J. Chad Hoyle, Caterina Mariotti, Katherine D. Mathews, Wolfgang Nachbauer, Susan Perlman, Sub H. Subramony, George Wilmot, Theresa Zesiewicz, Lisa Weissfeld & Colin Meyer Propensity-matched analysis comparing omaveloxolone treatment to Friedreich ataxia natural history data: a plain language summary , Future Neurology: 2025


Shiraishi DH, Saha S, Adanyeguh IM, Cocozza S, Corben LA, Deistung A, Delatycki MB, Dogan I, Gaetz W, Georgiou-Karistianis N, Graf S, Grisoli M, Henry PG, Jarola GM, Joers JM, Langkammer C, Lenglet C, Li J, Lobo CC, Lock EF, Lynch DR, Mareci TH, Martinez ARM, Monti S, Nigri A, Pandolfo M, Reetz K, Roberts TP, Romanzetti S, Rudko DA, Scaravilli A, Schulz JB, Subramony SH, Timmann D, França MC Jr, Harding IH, Rezende TJR; TRACK-FA Neuroimaging Consortium. Automated Deep Learning-based Segmentation of the Dentate Nucleus Using Quantitative Susceptibility Mapping MRI , Radiol Artif Intell .: 2025,e240478.